So, evidence-based guideline for GH replacement therapy has proposed to start appropriate dose of GH as soon as documenting persistent growth failure in children with stage 3-5 End Stage Renal Disease (ESRD) or on dialysis. This evidence concerns the gene GH1 and Growth delay.